Back to Search
Start Over
Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma
- Source :
- HemaSphere, HemaSphere, 2022, 6 (2), ⟨10.1097/HS9.0000000000000672⟩, HEMASPHERE, HemaSphere, Vol 6, Iss 2, p e672 (2022), HemaSphere, vol. 6, no. 2, pp. e672
- Publication Year :
- 2022
- Publisher :
- HAL CCSD, 2022.
-
Abstract
- International audience
Details
- Language :
- English
- ISSN :
- 25729241
- Database :
- OpenAIRE
- Journal :
- HemaSphere, HemaSphere, 2022, 6 (2), ⟨10.1097/HS9.0000000000000672⟩, HEMASPHERE, HemaSphere, Vol 6, Iss 2, p e672 (2022), HemaSphere, vol. 6, no. 2, pp. e672
- Accession number :
- edsair.doi.dedup.....c1d71d1366d46849d76820a33c2abd87